Patents by Inventor Brian Jeffrey Nickoloff

Brian Jeffrey Nickoloff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Respiratory Disease
    Publication number: 20230295290
    Abstract: Methods of preventing and/or treating ARDS with anti-IL17 antibodies, including dose regimens and pharmaceutical formulations of anti-IL17 antibodies for use in the prevention and/or treatment of ARDS.
    Type: Application
    Filed: September 26, 2022
    Publication date: September 21, 2023
    Inventors: Gaia GALLO, Venkatesh KRISHNAN, Sreekumar G. PILLAI, Brian Jeffrey NICKOLOFF
  • COMPOUNDS AND METHODS TARGETING INTERLEUKIN-19
    Publication number: 20230220062
    Abstract: The present invention provides compounds and methods targeting human interleukin-19, including therapeutic antibodies, pharmaceutical compositions and diagnostic applications useful in the field of immune-mediated diseases including psoriasis, atopic dermatitis, psoriatic arthritis, bronchial asthma and diabetic nephropathy.
    Type: Application
    Filed: January 25, 2023
    Publication date: July 13, 2023
    Inventors: Richard Earl HIGGS, Jr., Robert John KONRAD, Brian Jeffrey NICKOLOFF, Robert William SIEGEL, II
  • Compounds and methods targeting interleukin-19
    Patent number: 11591387
    Abstract: The present invention provides compounds and methods targeting human interleukin-19, including therapeutic antibodies, pharmaceutical compositions and diagnostic applications useful in the field of immune-mediated diseases including psoriasis, atopic dermatitis, psoriatic arthritis, bronchial asthma and diabetic nephropathy.
    Type: Grant
    Filed: June 17, 2020
    Date of Patent: February 28, 2023
    Assignee: Eli Lilly and Company
    Inventors: Richard Earl Higgs, Jr., Robert John Konrad, Brian Jeffrey Nickoloff, Robert William Siegel, II
  • COMPOUNDS AND METHODS TARGETING INTERLEUKIN-19
    Publication number: 20200354444
    Abstract: The present invention provides compounds and methods targeting human interleukin-19, including therapeutic antibodies, pharmaceutical compositions and diagnostic applications useful in the field of immune-mediated diseases including psoriasis, atopic dermatitis, psoriatic arthritis, bronchial asthma and diabetic nephropathy.
    Type: Application
    Filed: June 17, 2020
    Publication date: November 12, 2020
    Inventors: Richard Earl Higgs, JR., Robert John Konrad, Brian Jeffrey Nickoloff, Robert William Siegel, II